The Greatest Guide To Ago tumor
Founded immune markers nonetheless preserve their relevance for clinical final decision-generating in breast most cancers treatment with even extended meanings. Estrogen receptor (ER) stage must not only be classified in optimistic or detrimental. Reduced ER stages ≤10% of labeled cells should be taken care of in a different way (LoE 1a/A/AGO++).